TroyGScrogginsMD

Radiation Oncology • New Orleans, LA

Physician

Join to view full profile

Dr. Scroggins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Scroggins' full profile

Already have an account?

Office
1514 Jefferson Hwy
New Orleans, LA 70121
Phone+1 504-842-4000

Education & Training

University of MarylandResidency, Radiation Oncology, 1987 - 1991
University of TennesseeInternship, Internal Medicine, 1986 - 1987
Washington University in St. Louis School of MedicineClass of 1986

Certifications & Licensure

LA State Medical License 1991 - 2025
MD State Medical License 1988 - 1991
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer Start of enrollment: 2008 Feb 01
Active, not recruiting
Phase 3
Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer Start of enrollment: 2008 Jun 01
Completed
Phase 3
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma Start of enrollment: 2009 Apr 15
Completed
Phase 3
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer Start of enrollment: 2012 May 01
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

11 citations
Personalizing Localized Prostate Cancer: Validation of a Combined Clinical Cell-cycle Risk (CCR) Score Threshold for Prognosticating Benefit From Multimodality Therapy.
Jonathan D. Tward, Thorsten Schlomm, Stephen Bardot, Daniel J. Canter, Troy Scroggins
Clinical Genitourinary Cancer. 2021-01-19
36 citations
Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectom...
Julia White, Kathryn Winter, Robert R. Kuske, John S. Bolton, Douglas W. Arthur
International Journal of Radiation Oncology, Biology, Physics. 2016-08-01
40 citations
RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma—year-5 toxicity and cosmesis
Rachel Rabinovitch, Kathryn Winter, Robert R. Kuske, John S. Bolton, Doug Arthur
Brachytherapy. 2014-01-01